CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-30 | Logos Global Management LP 10% owner | Sale | −27 | $27.02 | $730 | 199,973 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +15,000 | $26.17 | $393K | 214,973 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +9,098 | $25.55 | $232K | 224,071 |
| 2020-09-11 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +1,167.21 | 1,167.21 | ||
| 2020-09-11 | Kuwahara Jon See Remarks | Grant or award · Stock Option (Right to Buy) | +2,145.26 | 2,145.26 | ||
| 2020-09-11 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +18,278.14 | 18,278.14 | ||
| 2020-09-11 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +5,907.15 | 5,907.15 | ||
| 2020-09-11 | McBride John S. Director | Grant or award · Stock Option (Right to Buy) | +1,167.21 | 1,167.21 | ||
| 2020-03-19 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-03-19 | TURKEL CATHERINE C. President | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-03-19 | Kuwahara Jon See Remarks | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-01-14 | OrbiMed Israel GP Ltd. Director | Sale · Warrants to Purchase Common Stock | +646,204 | $0.20 | $129K | |
| 2020-01-14 | OrbiMed Israel GP Ltd. Director | Sale · Warrants to Purchase Common Stock | +646,204 | $0.20 | $129K | |
| 2020-01-14 | Chimovits Erez Director | Sale · Warrants to Purchase Common Stock | +646,204 | $0.20 | $129K | 0 |
| 2020-01-14 | Chimovits Erez Director | Sale · Warrants to Purchase Common Stock | +646,204 | $0.20 | $129K | 0 |
| 2019-09-26 | Kuwahara Jon See Remarks | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-09-26 | TURKEL CATHERINE C. President | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-09-26 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-07-11 | McBride John S. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-07-11 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 7 of 15 · 300 trades